ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.990
-0.030 (-1.49%)
Aug 14, 2025, 11:26 AM - Market open
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $209.63 million as of August 14, 2025. Its market cap has increased by 32.35% in one year.
Market Cap
209.63M
Enterprise Value
92.47M
1-Year Change
32.35%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $209.63M, a decrease of -32.11%. That is a compound annual growth rate of -3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 205.70M | -7.88% |
| Dec 31, 2024 | 223.30M | 33.87% |
| Dec 29, 2023 | 166.80M | -39.78% |
| Dec 30, 2022 | 277.00M | -53.81% |
| Dec 31, 2021 | 599.70M | 164.07% |
| Dec 31, 2020 | 227.10M | -46.89% |
| Dec 31, 2019 | 427.60M | -15.11% |
| Dec 31, 2018 | 503.70M | 568.92% |
| Dec 29, 2017 | 75.30M | -34.18% |
| Dec 30, 2016 | 114.40M | -43.53% |
| Dec 31, 2015 | 202.60M | -55.40% |
| Dec 31, 2014 | 454.30M | 47.12% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 602.85B |
| Johnson & Johnson | 419.32B |
| AbbVie | 359.58B |
| UnitedHealth Group | 246.61B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.35B |